MDPLF
Medicus Pharma Ltd., a biotech/life sciences company, focuses on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. It is developing SkinJect with an indication for basal cell carcinoma. The company is headquartered in Toronto, Canada.
MDPLF (MDPLF) - Total Liabilities
Latest total liabilities as of June 2024: $2.33 Million USD
Based on the latest financial reports, MDPLF (MDPLF) has total liabilities worth $2.33 Million USD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MDPLF - Total Liabilities Trend (2021–2023)
This chart illustrates how MDPLF's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MDPLF Competitors by Total Liabilities
The table below lists competitors of MDPLF ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mobile Max-M
TA:MBMX
|
Israel | ILA2.40 Million |
|
IREN (TZ8.SG)
STU:TZ8
|
Germany | €8.74 Billion |
|
Precious Metals And Mining Trust
TO:MMP-UN
|
Canada | CA$202.00K |
|
Wins Finance Holdings Inc
PINK:WINSF
|
USA | $49.15 Million |
|
Food Culture Inc.
PINK:FCUL
|
USA | $4.05 Million |
|
Cannagistics Inc
PINK:CNGT
|
USA | $6.71 Million |
Liability Composition Analysis (2021–2023)
This chart breaks down MDPLF's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MDPLF's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MDPLF (2021–2023)
The table below shows the annual total liabilities of MDPLF from 2021 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.09 Million | -91.29% |
| 2022-12-31 | $12.48 Million | +17.92% |
| 2021-12-31 | $10.58 Million | -- |